Endexx Corporation, a provider of phytonutrient based food and nutritional products, completed the first round of production of its pet product line, Phyto-Bites, a cannabidiol-infused soft chew treats for dogs. Cannabidiol, or CBD, is a chemical extracted from Cannabis plants (hemp or marijuana) that may have medical uses.
The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation, according to Endexx.
"We increased our first full production run by 20-fold due to the high demand we've been experiencing, as well as all the positive testimonials from our clients,” said Todd Davis, CEO of Endexx. “We plan on doing another production run in November. We are scaling up our operations for the first calendar year quarter with distribution through national chains and stores across the country.
“Initially, products are going out to our health and wellness, and vitamin stores that we are currently serving. However, we will be targeting up to five national chains over the course of the next 12 months, which will broaden our customer base and increase revenue as we meet demand. Obviously this is great news for our shareholders and comes on the tail of us recently announcing our best quarter ever."
Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids.
The company has two technology products and services that launched in 2014. The M3hub and the Autospense. Based on principles developed by the pharmacological industry, the m3hub tracks pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations.
While cat trends continue, the pandemic has added to overall slow-growth treatment of the cat food market.
Premiumization and humanization, as well as automation, fueled continued operation growth in spite of the COVID-19 pandemic.